Concepedia

Author

Yuta Mitobe

Saiseikai Niigata Daini HospitalORCID

Also Known As

Y. Mitobe, YUTA MITOBE, Yuta MITOBE, Yuta Mitobe

59

Publications

362

Citations

10

H-Index

22

Concepts

All Affiliations

Saiseikai Niigata Daini HospitalSapporo UniversityTeikyo UniversityNiigata University of Health and WelfareKeio University
YM

About

Yuta Mitobe is an author at Saiseikai Niigata Daini Hospital specializing in kinesiology, health sciences, and exercise.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

50

2

Medicine

2

2

50

3

Applied Physiology

2

2

50

4

Exercise Physiology

2

2

50

5

Kinesiology

2

2

50

Yuta Mitobe

×

8

Publications

164

Citations

8

H-Index

YearCitations

Relationship Between Sarcopenia and Both Physical Activity and Lifestyle in Patients With Chronic Liver Disease

Kazuki Ohashi, Toru Ishikawa, Asami Hoshi,

Journal of Clinical Medicine Research

2018

34

Skeletal Muscle Index at Intensive Care Unit Admission Is a Predictor of Intensive Care Unit-Acquired Weakness in Patients With Sepsis

Yuta Mitobe, Shinichiro Morishita, Kazuki Ohashi,

Journal of Clinical Medicine Research

2019

34

Differences in Balance Function Between Cancer Survivors and Healthy Subjects: A Pilot Study

Shinichiro Morishita, Yuta Mitobe, Atsuhiro Tsubaki,

Integrative Cancer Therapies

2018

27

Cancer survivors exhibit a different relationship between muscle strength and health-related quality of life/fatigue compared to healthy subjects

Shinichiro Morishita, Atsuhiro Tsubaki, Jack B. Fu,

European Journal of Cancer Care

2018

23

Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease

Kazuki Ohashi, Toru Ishikawa, Asami Hoshii,

Journal of Clinical Medicine

2021

14

Effect of levocarnitine administration in patients with chronic liver disease

Kazuki Ohashi, Toru Ishikawa, Asami Hoshii,

Experimental and Therapeutic Medicine

2020

11

CEP-1347 Targets MDM4 Protein Expression to Activate p53 and Inhibit the Growth of Glioma Cells

Yuta Mitobe, Yurika Nakagawa-Saito, Keita Togashi,

Anticancer Research

2022

11

HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated Progeny

Yurika Nakagawa-Saito, Shinichi Saitoh, Yuta Mitobe,

International Journal of Molecular Sciences

2022

10

Page 1